data13F

PTGX – Protagonist Therapeutics Inc

Held by 0 of 30 tracked investors in their latest 13F filing

Investors holding0
Combined shares0
Combined reported value$0

PTGX chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Ray Dalio0.00Closed0–Q3 2026
Stanley Druckenmiller0.00Closed0–Q3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Closed00.59
Q3 2026Ray Dalio narrow view Closed00.00
Q2 2026Stanley Druckenmiller narrow view Added 30.8%208,9000.14
Q2 2026Ray Dalio narrow view Added 75.7%9,2690.00
Q1 2026George Soros narrow view Closed00.16
Q1 2026Ray Dalio narrow view New5,2760.00
Q4 2025George Soros narrow view New100,0000.16

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q2 2026Stanley Druckenmiller narrow view Added 30.8%208,9000.14
Q2 2026Ray Dalio narrow view Added 75.7%9,2690.00
Q1 2026Ray Dalio narrow view New5,2760.00
Q4 2025George Soros narrow view New100,0000.16

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Closed00.59
Q3 2026Ray Dalio narrow view Closed00.00
Q1 2026George Soros narrow view Closed00.16

History

2 peakQ2 2026: 2 tracked investors
Q3 2025: 1 tracked investorsQ4 2025: 2 tracked investorsQ1 2026: 2 tracked investorsQ2 2026: 2 tracked investors
20252026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Ray Dalio–9.3K5.3K–––––
Stanley Druckenmiller–208.9K159.7K159.7K159.7K–––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).